Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Shareholders' Equity (Unaudited)

v3.19.1
Condensed Statements of Shareholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Sep. 30, 2017 13,812,821      
Balance at Sep. 30, 2017 $ 138,128 $ 55,406,888 $ 8,980,104 $ 64,525,120
Balance (in shares) at Dec. 31, 2017 13,824,191      
Balance at Dec. 31, 2017 $ 138,242 56,021,457 9,923,262 66,082,961
Balance (in shares) at Sep. 30, 2017 13,812,821      
Balance at Sep. 30, 2017 $ 138,128 55,406,888 8,980,104 64,525,120
Stock-based compensation expense   969,081   969,081
Restricted stock issuance, net (in shares) (1,409)      
Restricted stock issuance, net $ (14) 14    
Issuance of common stock under employee stock purchase plan (in shares) 14,242      
Issuance of common stock under employee stock purchase plan $ 142 148,117 148,259
Exercise of stock options, net of shares exchanged for payment (in shares) 5,675      
Exercise of stock options, net of shares exchanged for payment $ 58 17,891 17,949
Tax withholding related to vesting of restricted stock grants (in shares) (671)      
Tax withholding related to vesting of restricted stock grants $ (7) (9,255) (9,262)
Net income     637,782 637,782
Repurchase of common stock (in shares) (19,582)      
Repurchase of common stock $ (196) (235,828)   (236,024)
Balance (in shares) at Mar. 31, 2018 13,811,076      
Balance at Mar. 31, 2018 $ 138,111 56,296,908 9,617,886 66,052,905
Balance (in shares) at Dec. 31, 2017 13,824,191      
Balance at Dec. 31, 2017 $ 138,242 56,021,457 9,923,262 66,082,961
Stock-based compensation expense   485,794   485,794
Restricted stock issuance, net (in shares) 2,967      
Restricted stock issuance, net $ 30 (30)    
Exercise of stock options, net of shares exchanged for payment (in shares) 2,600      
Exercise of stock options, net of shares exchanged for payment $ 26 14,674 14,700
Net income     (305,376) (305,376)
Repurchase of common stock (in shares) (18,682)      
Repurchase of common stock $ (187) (224,987)   (225,174)
Balance (in shares) at Mar. 31, 2018 13,811,076      
Balance at Mar. 31, 2018 $ 138,111 56,296,908 9,617,886 66,052,905
Balance (in shares) at Sep. 30, 2018 13,646,553      
Balance at Sep. 30, 2018 $ 136,466 55,483,759 13,254,651 68,874,876
Balance (in shares) at Dec. 31, 2018 13,662,456      
Balance at Dec. 31, 2018 $ 136,625 56,161,405 14,264,611 70,562,641
Balance (in shares) at Sep. 30, 2018 13,646,553      
Balance at Sep. 30, 2018 $ 136,466 55,483,759 13,254,651 68,874,876
Stock-based compensation expense   1,102,190   1,102,190
Restricted stock issuance, net (in shares) (352)      
Restricted stock issuance, net $ (4) 4    
Issuance of common stock under employee stock purchase plan (in shares) 17,312      
Issuance of common stock under employee stock purchase plan $ 173 145,767 145,940
Exercise of stock options, net of shares exchanged for payment (in shares) 5,440      
Exercise of stock options, net of shares exchanged for payment $ 54 (30) 24
Tax withholding related to vesting of restricted stock grants (in shares) (545)      
Tax withholding related to vesting of restricted stock grants $ (5) (6,671) (6,676)
Net income     1,377,902 1,377,902
Balance (in shares) at Mar. 31, 2019 13,668,408      
Balance at Mar. 31, 2019 $ 136,684 56,725,019 14,632,553 71,494,256
Balance (in shares) at Dec. 31, 2018 13,662,456      
Balance at Dec. 31, 2018 $ 136,625 56,161,405 14,264,611 70,562,641
Stock-based compensation expense   563,666   563,666
Restricted stock issuance, net (in shares) 3,486      
Restricted stock issuance, net $ 35 (35)    
Exercise of stock options, net of shares exchanged for payment (in shares) 2,466      
Exercise of stock options, net of shares exchanged for payment $ 24 (17) 7
Net income     367,942 367,942
Balance (in shares) at Mar. 31, 2019 13,668,408      
Balance at Mar. 31, 2019 $ 136,684 $ 56,725,019 $ 14,632,553 $ 71,494,256